MVM
Medicxi Ventures Management Portfolio holdings
AUM
$427M
This Quarter Return
+15.4%
1 Year Return
+42.94%
3 Year Return
+262.94%
5 Year Return
+109.92%
10 Year Return
–
AUM
$238M
AUM Growth
+$238M
(-0.87%)
Cap. Flow
+$1.17M
Cap. Flow
% of AUM
0.49%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
NewAmsterdam Pharma
NAMS
|
$21.8M |
Top Sells
| 1 |
Vaxcyte
PCVX
|
$20.6M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vaxcyte
PCVX
$4B
| $69.9M | 29.35% | 1,457,300 -430,178 | -23% | -$20.6M |
|
|
CNTA
2
Centessa Pharmaceuticals
CNTA
$2.25B
| $61.9M | 25.99% | 19,963,157 | – | – |
|
3
Aura Biosciences
AURA
$389M
| $31.9M | 13.41% | 3,039,892 | – | – |
|
4
Phathom Pharmaceuticals
PHAT
$864M
| $27.9M | 11.71% | 2,484,274 | – | – |
|
5
Merus
MRUS
$4.98B
| $24.8M | 10.4% | 1,600,000 | – | – |
|
|
6
NewAmsterdam Pharma
NAMS
$2.71B
| $21.8M | 9.16% | +2,000,000 | New | +$21.8M |
|
|
OBSV
7
DELISTED
ObsEva SA Ordinary Shares
OBSV
| – | – | 0 | – | – |
|